2025-03-29 13:23:00
Latest Post
Cineline India Ltd monetizes Hotel Asset for INR 270 crores, becomes Net Debt-Free company
Emami Realty Limited appoints Ms. Ishani Ray as additional director
The Ramco Cements Ltd increases cement grinding capacity by 0.4 MTPA
Manappuram Finance Limited board approves fund raising program for FY 2025-26
Adani Renewable Energy Fifty Seven Ltd commissions incremental solar power project of 37.50 MW at Khavda
Stock Report
Rossari Biotech Ltd posts consolidated PAT of Rs. 24.08 crores in Q4FY22
Posted On : 2022-05-19 23:19:22( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 440.904 crores during the period ended March 31, 2022 as compared to Rs. 433.771 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 24.081 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 22.795 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 4.35 for the period ended March 31, 2022 as compared to Rs. 4.07 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 440.904 crs | ₹433.771 crs |  1.64% |
| Net Profit | ₹24.081 crs | ₹22.795 crs | 5.64% |
| EPS | ₹4.35 | ₹4.07 | 6.88% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 440.904 crores during the period ended March 31, 2022 as compared to Rs.220.262 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.24.081 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.22.427 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.4.35 for the period ended March 31, 2022 as compared to Rs.4.29 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 440.904 crs | ₹220.262 crs | 100.17% |
| Net Profit | ₹24.081 crs | ₹22.427 crs | 7.38% |
| EPS | ₹4.35 | ₹4.29 | 1.40% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1494.970 crores during the Financial Year ended March 31, 2022 as compared to Rs.718.049 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.97.674 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.80.220 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.17.70 for the Financial Year ended March 31, 2022 as compared to Rs.15.47 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹1494.970 crs | ₹718.049 crs | 108.20% |
| Net Profit | ₹97.674 crs | ₹80.220 crs | 21.76% |
| EPS | ₹17.70 | ₹15.47 | 14.41% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 884.90 as compared to the previous close of Rs. 912.30. The total number of shares traded during the day was 11852 in over 1542 trades.
The stock hit an intraday high of Rs. 902.95 and intraday low of 861.15. The net turnover during the day was Rs. 10499418.00.
